Main > ONCOLOGY (**) > NeuroBlastoma > TREAT.: > UK. E. DisialoganGlioside-2 MAb IV

---

Inj.

UK. E. DisialoganGlioside-2 MAb IV's subsections
(*) CN Approval Date: 2021. 08.17.
(*) EU CE Mark Date: 2017. 05.09
Company
Company CN
Generic Name: DinutuxiMAb Beta
GlycoPeptide
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 08.17.
PR Web-Site
TradeMark

UK. E. DisialoganGlioside-2 MAb IV's products
This section has no products